Lee Pharmaceuticals, Inc. filed its 1-A on Sep 13, 2022 for the period ending Dec 31, 2021. In this report its auditor, Accell Audit & Compliance, P.A, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.001 USD | +25.00% | +100.00% | -96.12% |
1st Jan change | Capi. | |
---|---|---|
-96.12% | 613K | |
+32.21% | 285B | |
+9.02% | 75.95B | |
+4.61% | 68.85B | |
+0.81% | 66.96B | |
+18.45% | 53.72B | |
+25.86% | 51.56B | |
-1.64% | 47.87B | |
+34.08% | 45.96B | |
+18.67% | 38.39B |
- Stock Market
- Equities
- RONN Stock
- News RONN Inc.
- Lee Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt